Search - tctmd.com

Displaying 481 - 500 of 1021

Sort: Relevancy | Date

Novel Therapies for Superficial Venous Insufficiency: Thermal and Non-thermal Technologies

Presentation TCT 2018

Novel Therapies for Superficial Venous Insufficiency: Thermal and Non-thermal Technologies

Presenter: Raghu Kolluri, Mahmood K. Razavi

September 21, 2018

Existing and Future Therapies for Chronic Deep Vein Thrombosis

Presentation TCT 2018

Existing and Future Therapies for Chronic Deep Vein Thrombosis

Presenter: Raghu Kolluri, Mahmood K. Razavi, Rahul S. Patel

September 21, 2018

Status of Venous Stents to Treat Venous Obstruction

Presentation TCT 2018

Status of Venous Stents to Treat Venous Obstruction

Presenter: Raghu Kolluri, Mahmood K. Razavi

September 21, 2018

After the ATTRACT Trial: Which Patients With Acute Deep Vein Thrombosis Should Receive Endovascular Therapy?

Presentation TCT 2018

After the ATTRACT Trial: Which Patients With Acute Deep Vein Thrombosis Should Receive Endovascular Therapy?

Presenter: Raghu Kolluri, Mahmood K. Razavi, Teresa L. Carman

September 21, 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

September 14, 2018

TCTMD’s Top 10 Most Popular Stories for August 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

September 04, 2018

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

News Conference News ESC 2018

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

August 31, 2018

Medically Ill Pa+ent Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presentation ESC 2018

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presenter: Alex C. Spyropoulos

August 27, 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

August 26, 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

August 20, 2018

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

News Daily News

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

August 13, 2018

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

News Daily News

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Michael O'Riordan

July 23, 2018

News Industry News

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

July 11, 2018

Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib

News Daily News

Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib

July 06, 2018

VTE Risk Higher in Surgical Patients Who Get Transfusions

News Daily News

VTE Risk Higher in Surgical Patients Who Get Transfusions

June 13, 2018

News Industry News

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

May 24, 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

May 04, 2018

News Industry News

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

April 19, 2018

$Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina$

News Daily News

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

April 16, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.